Maria Figueroa,Kirsten Meldi,Tingting Qin,Valeria Santini
申请号：
US15540524
公开号：
US20170368091A1
申请日:
2015.12.21
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Provided herein is technology relating to predicting a subject's resistance or responsiveness to a decitabine based therapy and particularly, but not exclusively, to methods, compositions, and related uses for predicting a subject's resistance or responsiveness to a decitabine based therapy wherein the subject is diagnosed with chronic myelomonocytic leukemia.
